type here...

CATEGORIES

Therapies and Therapists

LATEST

1234Page 1 of 4

TRENDING

EDITORS CHOICE

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

Gil Bashe, Medika Life Editor -
First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

AI Presents Dangers That Hide With Incredible Ease

Pat Farrell PhD -
Artificial intelligence, aka AI, has become so advanced that it might be difficult to know whether you are speaking to a live person or...

Suicidology Is Corrupted by Researchers Who Say Things That Aren’t in Their Data

James Coyne -
Journals are a big part of the problem of misrepresented or misinterpreted data. They seduce researchers with temptations that they cannot resist

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories